Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Doboczky has served as Chairman of the Board of Directors of Hovione Holding AG since 2024.
September 8, 2026
By: Charlie Sternberg
Editor’s Take: Hovione’s previous CEO, Dr. Jean Luc Herbeaux, decided to step down from his role in May 2026.
Hovione Holding AG has appointed Stefan Doboczky as Chief Executive Officer (CEO), effective April 1, 2027.
Doboczky has served as Chairman of the Board of Directors of Hovione Holding AG since 2024. He will step down as Chairman upon assuming the role of CEO.
The appointment marks a return to the pharmaceutical industry for Doboczky, who spent more than 17 years at Royal DSM, where he rose to become a member of the Executive Board responsible for the group’s global pharmaceutical portfolio and for its growth in Asia.
He subsequently spent 11 years as CEO of listed, private-equity-owned and corporate-owned industrial companies, including Lenzing AG, Heubach GmbH and Borealis AG. Following the combination of Borealis, Borouge and NOVA Chemicals into Borouge International, he took on the role of Chief Commercial Officer and Deputy Chairman of the Executive Board of the merged group. He will hand over these responsibilities to his successor on October 1, 2026 and remains available for six months to support the transition.
Doboczky holds a Master’s degree in technical chemistry and a doctorate in natural sciences, both from Vienna University of Technology (TU Wien), Austria, and an MBA from IMD, Lausanne, Switzerland.
“I am honored to take on the role of CEO at Hovione and to move from my role as Chairman of the Board into the operational leadership of the company,” said Doboczky. “I look forward to working closely with Hovione’s global leadership team and the Board to strengthen our international presence, drive innovation and create sustainable value for our customers, partners and shareholders.”
In April, Contract Pharma had the opportunity to tour Hovione’s expanded manufacturing facility in East Windsor, NJ. Read about what we saw.
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
